<DOC>
	<DOCNO>NCT00276029</DOCNO>
	<brief_summary>The purpose study investigate whether administration etanercept patient severe asthma improve asthma relate quality life measure degree reactivity airway</brief_summary>
	<brief_title>TNF Alpha Refractory Asthma</brief_title>
	<detailed_description>Although steroid dependent asthma represent small population patient asthma , consume disproportionately large amount health resource burden attribute asthma . Treatment option group extremely limit ; development effective treatment group patient priority , increase individual patient quality life long term reduction health spending . This randomise , double blind , placebo control , cross trial investigate efficacy soluble TNF receptor , etanercept , severe , steroid dependant asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Symptomatic asthma Methacholine PC20 &lt; 8mg/ml History poor treatment concordance History tuberculosis Radiographic evidence previous tuberculosis Recent tuberculosis contact Respiratory tract infection within 3 month Current Smoker Exsmoker 5 pack year Symptomatic comorbid condition Contraindication etanercept Pregancy Breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2004</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Refractory</keyword>
</DOC>